Pacific Capital Partners’s CONMED CNMD Stock Holding History

Pacific Capital Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,500	Closed	-$386K	–	46
2025 Q4	$386K	Sell	9,500 -32,000	-77%	-$1.39M	0.41%	34
2025 Q3	$1.95M	Sell	41,500 -19,498	-32%	-$1.01M	2.17%	20
2025 Q2	$3.18M	Sell	60,998 -30,142	-33%	-$1.65M	2.98%	14
2025 Q1	$5.5M	Sell	91,140 -9,946	-10%	-$641K	3.48%	11
2024 Q4	$6.92M	Buy	101,086 +54,888	+119%	+$3.83M	4.07%	8
2024 Q3	$3.32M	Buy	46,198 +7,500	+19%	+$529K	1.95%	17
2024 Q2	$2.68M	Hold	38,698	–	–	1.78%	16
2024 Q1	$3.1M	Buy	38,698 +14,698	+61%	+$1.31M	2.03%	18
2023 Q4	$2.63M	Sell	24,000 -2,337	-9%	-$242K	1.98%	18
2023 Q3	$2.66M	Buy	+26,337	New	+$3.03M	1.61%	24

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Pacific Capital Partners's CNMD Position: Q1 2026 in Review

Pacific Capital Partners sold out of CONMED (CNMD) in Q1 2026, closing a stake of 9,500 shares — an estimated $386K sold.

Pacific Capital Partners first reported a position in CNMD in Q3 2023 and held it in 10 quarters. The position peaked at $6.92M in Q4 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Pacific Capital Partners reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
Pacific Capital Partners sold 9,500 CONMED shares in Q1 2026, an estimated $386K.
Pacific Capital Partners first reported a position in CONMED in Q3 2023 and held it in 10 quarters.
Pacific Capital Partners's CONMED position peaked at $6.92M in Q4 2024.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Pacific Capital Partners's 13F filing for Q1 2026, filed 9 Apr 2026.